SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001213900-21-007730
Filing Date
2021-02-09
Accepted
2021-02-09 15:52:53
Documents
2
Group Members
REGALS CAPITAL MANAGEMENT LPREGALS FUND LP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM SC 13G ea135034-sc13gaslager_oramed.htm SC 13G/A 81056
2 AGREEMENT OF JOINT FILING. ea135034ex99-1_oramed.htm EX-99.1 7254
  Complete submission text file 0001213900-21-007730.txt   89866
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Subject) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: SC 13G/A | Act: 34 | File No.: 005-79895 | Film No.: 21606257
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 WEST 57TH STREET, 9TH FLOOR NEW YORK NY 10019
Business Address
Slager David Mark (Filed by) CIK: 0001477733 (see all company filings)

Type: SC 13G/A